HCWB HCW Biologics Inc. Forecast, Technical & Fundamental Analysis
HCW Biologics Inc is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation... Show more
HCWB is expected to report earnings to fall 154.05% to -120 cents per share on August 07
Q2'26
Est.
$-1.20
Q1'26
Beat
by $17.82
Q4'25
Beat
by $1.41
Q3'25
Beat
by $0.28
Q2'25
Missed
by $2.70
The last earnings report on May 14 showed earnings per share of $2.22, beating the estimate of -1560 cents. With 26.81K shares outstanding, the current market capitalization sits at 5.11M.
A.I.dvisor indicates that over the last year, HCWB has been loosely correlated with APLM. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if HCWB jumps, then APLM could also see price increases.
HCWB in upward trend: price may ascend as a result of having broken its lower Bollinger Band on July 20, 2026
HCWB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 44 cases where HCWB's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where HCWB's RSI Oscillator exited the oversold zone, of 38 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 73 cases where HCWB's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for HCWB just turned positive on July 30, 2026. Looking at past instances where HCWB's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .
Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where HCWB advanced for three days, in of 165 cases, the price rose further within the following month. The odds of a continued upward trend are .
Bearish Trend Analysis
HCWB moved below its 50-day moving average on June 26, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for HCWB crossed bearishly below the 50-day moving average on June 30, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HCWB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for HCWB entered a downward trend on July 31, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.887) is normal, around the industry mean (19.620). P/E Ratio (0.000) is within average values for comparable stocks, (38.277). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.532). Dividend Yield (0.000) settles around the average of (0.020) among similar stocks. P/S Ratio (0.257) is also within normal values, averaging (420.906).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. HCWB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HCWB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
